Dr. Kathryn Beckermann, MD

• Hematology & Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports, 2020-12-22

• Editorial: Case reports in renal cell carcinoma, 2023-03-01

• Novel insights into the pathogenesis and treatment of NRAS mutant melanoma, 2021-08-11

• The transcription factor Bhlhe40 programs mitochondrial regulation of resident CD8+T cell fitness and functionality, 2019-09-17

• Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma, 2017-01-17

• PD-1/PD-L1 Blockade in Renal Cell Cancer, 2016-07-28

• Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma, 2021-11-03

• Strategies to Overcome Therapeutic Resistance in Renal Cell Carcinoma, 2017-01-11

• The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma, 2022-08-07

• Emerging Targets in Clear Cell Renal Cell Carcinoma, 2022-10-04

• Small cell lung cancer transformation as a mechanism of resistance to PD-1 therapy inKRASmutant lung adenocarcinoma: A report of two cases, 2018-12-10

• Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy, 2017-02-21

• Modeling Clear Cell Renal Cell Carcinoma and Therapeutic Implications, 2020-03-02

• Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand, 2020-06-27

• Fluorescence-based measurement of cystine uptake through xCT shows requirement for ROS detoxification in activated lymphocytes, 2016-09-02

• Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma, 2021-03-23

• PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma, 2020-05-01

• Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes, 2021-08-31

• Single-Cell Protein Activity Analysis Identifies Recurrence-Associated Renal Tumor Macrophages, 2021-05-20

• Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma, 2020-11-19

• The association of BMI and outcomes in metastatic melanoma: A retrospective, multicohort analysis of patients treated with targeted therapy, immunotherapy, or chemotherapy, 2018-02-12

• Leptin Augments Anti-Tumor Immunity in Obesity by Repolarizing Tumor-Associated Macrophages, 2021-11-12